Successful treatment of Helicobacter Pylori-negative gastric MALT lymphoma with rituximab

Digestive Diseases and Sciences

Volumn 51, Issue 4, 2006, Pages 775-778

  Chaudhary, Nadeem ^a   Ozer, Howard ^a   Huard, David ^a   Lightfoot, Stan ^a   Mesiya, Sikandar ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Digestive Disease Specialists Inc   (United States)

Author keywords

Gastric mucosal associated lymphoid tissue (MALT) lymphoma; Helicobacter pylori (H. pylori); Rituximab

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; RITUXIMAB;

AGED; ARTICLE; CASE REPORT; CHIMERA; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LYMPHOID TISSUE; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; NEOPLASM STAGING; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33645842762     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3205-0     Document Type: Article

References (15)

1. Lewin KJ, Ranchod M, Dorfman RF, et al.: Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease. Cancer 42:693-707, 1978
2. Ahmad A, Govil Y, Frank BB: Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 98:975-986, 2003
3. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al.: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176, 1991
4. Eck M, Schmauber B, Haas R, et al.: MALT-type lymphoma of the stomach is associated with H. pylori strains expressing the Cag A protein. Gastroenterology 112:1482-1486, 1997
5. Crabtree JE, Spencer J: Immunological aspects of Helicobacter pylori infection and malignant transformation of B cells. Semin Gastrointest Dis 7:30-40, 1996
6. Rollinson S, Levene AP, Mensah FK, et al.: Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 102:1007-1011, 2003
7. Hellmig S, Vollenberg S, Fischbach W, et al.: IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. Blood 104:2994-2995, 2004
8. Wootherspoon AC, Doglioni C, Diss TC, et al.: Regression of primary low grade B-cell lymphoma of mucosa-associated lymphoid tissue. Lancet 342:575-577, 1993
9. Hammel P, Haioun C, Chaummette M, et al.: Efficacy of single agent chemotherapy in low grade B-cell MALT lymphoma with prominent gastric expression. J Clin Oncol 13:2524-2529, 1995
10. Iocher M, Muller R, Ross D, et al.: Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiother Oncol 42:37-41, 1997
11. McLaughlin P, Grillo-Lopez A, link B, et al.: Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four dose treatment program. J Clin Oncol 16:2825-2833, 1998
12. Conconi A, Martinelli G, Thieblemont C, et al.: Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102:2741-2745, 2003
13. Martinelli G, Laszlo D, Ferreri AJ, et al.: Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 23:1979-1983, 2005
14. Datta YH, Kampalath B, Binion DG: Rituximab-induced remission of a gastric MALT lymphoma. Leu Lymph 45:1297-1299, 2004
15. Nuckel H, Meller D, Steuhl KP, et al.: Anti-CD20 monoclonal antibody therapy in relapsed MALR lymphoma of the conjunctiva. Eur J Haematol 73:258-262, 2004